Jazz Pharmaceuticals
JAZZ
#1410
Rank
S$19.06 B
Marketcap
S$297.04
Share price
-2.62%
Change (1 day)
29.17%
Change (1 year)

EPS for Jazz Pharmaceuticals (JAZZ)

EPS in 2026 (TTM): S$4.74

According to Jazz Pharmaceuticals's latest financial reports the company's current EPS (TTM) is S$4.68. In 2025 the company made an earnings per share (EPS) of S-$7.47 a decrease over its 2024 EPS that were of S$11.75.

EPS history for Jazz Pharmaceuticals from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$4.74-163.45%
2025S-$7.47-163.56%
2024S$11.7539.08%
2023S$8.45-285.03%
2022S-$4.57-34.2%
2021S-$6.94-224.83%
2020S$5.56-53.25%
2019S$11.8923.59%
2018S$9.62-8.24%
2017S$10.4923.74%
2016S$8.4822.12%
2015S$6.94478.49%
2014S$1.20

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
S$6.77 44.63%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AmerisourceBergen
ABC
S$10.69 128.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
S-$1.38-129.48%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Teva Pharmaceutical Industries
TEVA
S$0.58-87.60%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel